For a limited time, new participants can receive a special bonus

Who may participate

Taking part in a clinical trial is an important and personal decision, and we hope it is one you will consider.

This study is seeking healthy adult volunteers, meaning that the participants will not have the condition being studied and are in overall good health. In addition to the criteria listed, participants must meet the following requirements:    

  • Willing and able to travel to our research facility in New Haven, CT
  • Willing to take a study drug 
  • Able to meet all study visit requirements  

There are other requirements for participation in this study. The study staff will explain these to you during the screening process.


Do you know someone who may meet these requirements? Refer a friend and you may be eligible to receive a bonus.

The disease, disorder, syndrome, illness, or injury that is being studied. On, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

18-65 years

The age a person must be to participate in a clinical trial.

All sexes

The sex of people who may participate in a clinical trial. Sex is a person’s classification based on assignment at birth. Eligibility based on sex is distinct from eligibility based on gender.

Referral Bonus

Click “Get Started” for program details. Compensation may be provided on a loadable debit card or by paper check in US dollars.  The New Haven PCRU reserves the right to determine method of payment, determine eligibility, or change or terminate this program at any time.

Each clinical study has its own guidelines for who can participate, called eligibility criteria. However, only the research study staff can determine if you qualify to enroll in the study.

What to expect

If this study may be a fit for you, you will be invited to a screening visit at our facility in New Haven, CT.  If you qualify for the study, there may be a period of up to 28 days before dosing begins.

If you choose to participate, you will be asked to stay at our facility for 15 consecutive nights. During your stay, you will receive up to 10 once-daily doses of the study drug and 2 doses of an additional medication to see if there is any effect when taken together. All doses are given orally (by mouth).

Throughout the study, staff will closely monitor your health status and collect data, such as the levels of the study drug in your blood. All study procedures will be clearly explained to you during screening. You may also read about them in the consent form below.

Required overnight stays
15 consecutive overnights

A participant may be required to stay overnight at the PCRU for observation and study procedures. The number and length of overnight stays is determined by the design of the study.

Long-term follow up
1 phone call

Some studies require the study team to stay in contact with the participant for a period of time after the participant completes the main part of the study. This long-term follow up is to collect additional information on the study drug over time.

How long is this study?
About 42 days

This is the time between first dose and final follow-up call or visit.  This does not include the time between screening and dosing, which can be up to 28 days.

Up to $5,230 upon completion of the study

Participants in clinical trials at the PCRU receive financial compensation for their participation. The amount depends on factors like length of the stay, total number of study visits, and the nature of the study procedures.

Interested in participating?

Complete and submit this form, and a Pfizer Clinical Research Unit (PCRU) representative will contact you.

You may also call 1-800-254-6398 and speak with a PCRU representative to learn more.

The personal data gathered here will be collected, processed, and maintained in a confidential manner. Your information will be stored in our research units database. We may use this information to invite you to participate in this clinical study, as well as other current and future clinical studies at the PCRU. You will have full access to your records at the Pfizer New Haven Clinical Research Unit and the opportunity to correct them if necessary.